The prevalence of vancomycin-resistant Enterococcus faecium varies across 43 geographical regions yet little is known about its population structure in Latin 44 America. Here, we provide a complete genomic characterization of 55 45 representative Latin American VREfm recovered from 1998-2015 in 5 countries. 46 We found that VREfm population in the region is structured into two main clinical 47 clades without geographical clustering. To place our regional findings in context, 48 we reconstructed the global population structure of VREfm by including 285 49 genomes from 36 countries from 1946-2017. Our results differ from previous 50 studies showing an early branching of animal related isolates and a further split of 51 clinical isolates into two sub-clades, all within clade A. The overall phylogenomic 52 structure was highly dependent on recombination (54% of the genome) and the 53 split between clades A and B is estimated to have occurred more than 3585 years 54 BP. Furthermore, while the branching of animal isolates and clinical clades was 55 predicted to have occur ~894 years BP, our molecular clock calculations suggest 56 that the split within the clinical clade occurred around ~371 years BP. By including 57 isolates from Latin America, we present novel insights into the population structure 58 of VREfm and revisit the evolution of this pathogen. 59 60 61 62 63 64 Enterococci are predominantly non-pathogenic gastrointestinal commensal 65 bacteria that occasionally cause human infections. Among them, Enterococcus 66 faecalis and Enterococcus faecium represent the species that account for most 67 clinically relevant infections. In particular, E. faecium has been able to adapt to the 68 hospital environment, emerging during the last few decades as a leading cause of 69 health-care infections worldwide, and becoming the most challenging species to 70 treat 1,2 . 71 Genome plasticity, the presence of multiple antibiotic resistance determinants, and 72 the lack of therapeutic options have contributed to the adaptation of E. faecium to 73 hospital environments 3,4 . Moreover, high recombination rates and the acquisition of 74 mobile elements in the genome of E. faecium also have driven this evolutionary 75 process 5 . In addition, the enrichment of virulence determinants, such as surface 76 proteins and phosphotransferase systems (particularly PTS clin , a putative factor 77 found to contribute to the intestinal colonization in a murine model) seems to 78 provide an advantage to the hospital adaptive process 3,6 . Furthermore, functional 79 gene groups, such as those involved in galactosamine metabolism, bile hydrolysis 80 and phosphorus utilization, are also abundant in E. faecium clinical strains 81 compared to non-clinical isolates, suggesting that specific metabolic factors have 82 also facilitated adaptation 7 .
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split into two main clades (Clade I and Clade II, marked in red and green, 154 respectively). Clade I included all the ST412 isolates, while Clade II had all the 155 ST17 isolates from our sample. We observe that the emergence of VREfm in 156 Colombia was associated with Clade II, including the first VREfm (described in 157 1998) and representatives from the first national surveillance (2001 to 2002) . 158 Additionally, ST412 was reported in 2005 and, since then, ST17 and ST412 seem 159 to be the most prevalent STs in the country. Our previous results showed that Peru The resistome and virulome of Latin American VREfm 167 In order to characterize antibiotic resistance determinants, we built resistome 168 profiles by detecting acquired resistance genes and mutations known to confer 169 resistance to linezolid, ciprofloxacin and daptomycin. All the VREfm isolates from 170 our collection were resistant to vancomycin (MIC90 >256 µg/ml) and teicoplanin 171 (MIC90 64 µg/ml) ( Figure 1B) . The presence of vanA was confirmed in all isolates 172 by PCR assays. Consistently, we confirmed the presence of the entire vanA cluster 173 in 54 out of the 55 sequenced genomes. Of note, the genome of ERV69 lacked the 174 two-component regulatory system vanSR, although still exhibiting MICs of >256 µg/ml and 64 µg/ml for vancomycin and teicoplanin, respectively. The deletion of 176 the two-component regulatory system has been previously reported 27 . 177 High-level resistance to ampicillin was consistently found in all 55 E. faecium 178 isolates, a phenotype that was corroborated using comparisons of the PBP5 179 protein sequence using a machine-learning prediction model. This approach was 180 based on the amino acid changes present in the PBP5 protein across susceptible 181 and resistant isolates (see details in Methods).
182
High-level resistance to gentamicin was identified in 31% of the isolates of our 183 collection and, within the sequenced representatives, the presence of aac(6´)-184 aph(2") was detected in 49% of the genome sequences. High-level resistance to 185 streptomycin was identified in 39% of the Latin American VREfm isolates with a 186 high prevalence of the ant(6)-Ia gene (89%; n=49) in the sequenced genomes. 187 Fluoroquinolone resistance is very common in E. faecium. All isolates in our 188 collection were fluoroquinolone-resistant and we were able to predict the presence 189 of substitutions in GyrA and ParC associated with this phenotype. Table 1 ). We constructed a pangenome (29,503 224 orthogroups) and core genome (978 orthogroups). Using the core genome, we built 225 a phylogenomic tree of the species to show the evolutionary relationships among 226 isolates based on the variation of their genomic sequences. Figure 3 shows that, 227 as previously reported, we found a clear split into two main clades corresponding 228 to the previously designated clades A and B 3,22,24 . All Latin American isolates from 229 our clinical collection were in clade A. We compared the genomic characteristics 230 among the two main clades and found similar findings as published previously 231 (Supplementary table 2) 3 . However, our data showed that the core genome was 232 larger in clade B as compared to clade A (1,466 vs 1,182 orthogroups, 233 respectively).
234
Considering the relevance of E. faecium as a cause of hospital-associated 235 infections and that all Latin American isolates were grouped within clade A, we 236 sought to dissect the population structure of this clade when adding the genomes 237 of these isolates. Our first approach was based on a core genome (>90% 238 reconstruction), which contained 1,226 orthogroups and the isolate Com15, from 239 clade B, as the outgroup to root the tree. We observed two major subclades. The 240 first was composed of 52 genomes, most of which were from animal sources (57%, 241 n=30), related to the previously described subclade A2 3 . The second lineage 242 harboured 273 genomes, with 91% (n=228) corresponding to isolates obtained 243 from clinical sources (Supp. Figure 2A) , and related to the subclade A1 3 .
244
Previous studies have shown contradictory distributions of the subclades A1 and 245 A2 within clade A 20 ; suggesting that clade A2 is not in fact a clade, but rather 246 corresponds to the paraphyletic early branching lineages of clade A. To further 247 clarify the issue, we performed a phylogenomic analysis accounting for 248 recombination events within clade A. We used the variants found from paired 249 alignments of each genome against the chromosome of reference Aus0085 and 250 built a whole-genome multiple sequence alignment (WGMSA) of all genomes in the 251 clade. We used this alignment to create a maximum likelihood tree, which is 252 required for determining recombinant regions using ClonalFrameML 33 . The 253 average amount of recombination found in the 303 genomes belonging to clade A 254 was 19,539pb (Supp. figure 2C ). The total recombinant regions found across 255 clinical isolates encompassed 1.6 Mb (54% of the length of WGMSA). Interestingly, 256 the exclusion of recombinant regions considerably altered the structure of the tree, 257 and showed 7 early-branching subclades that included 73 genomes (mostly from 258 animal sources) rather than a split into clades A1 and A2.
259
Following these animal-related early branches, we observed a split into two main 260 subclades (Supp. Figure 2B ). Overall, these subclades were related to clinical 261 sources, exhibiting a high similarity in terms of prevalence of antibiotic resistance 262 and virulence determinants ( Supplementary table 3 ). We refer to them as clinically- 
280
In CRS-I, there were 23 different STs, with ST412 and 78 the most frequent (34% 281 and 11%, respectively) ( Figure 4 ). Importantly, we did not find a strong correlation 282 between MLST and the phylogenomic analysis, as isolates belonging to the same 283 ST were not all clustered in the same clades, and were distributed in different 284 groups in the phylogeny. In particular, 56% (n=9) of genomes from ST78 were in 285 CRS-I, while 37% (n=6) were in CRS-II. To further dissect this discrepancy, we 286 performed a phylogenetic reconstruction using only the sequences of the 7 MLST 287 loci and compared it against the phylogeny of Clade A. Our results showed that 288 14 many isolates from ST17, ST18, ST78, ST203, ST412 were in different clusters 289 and even formed subclades in the non-recombination reconstruction 290 ( Supplementary Figure 3 ).
291
In relation to antibiotic resistance determinants, we found important differences 292 comparing the presence/absence of genomic elements associated with antibiotic 293 resistance between the CRSs and the animal branches. Indeed, the animal-294 associated branches exhibited a lower prevalence of elements associated with 295 glycopeptide (34.2%), aminoglycoside (21.9%), ampicillin (9.5%) and 296 fluoroquinolone resistance (2.7%) compared to the CRS isolates, which harboured 297 these determinants in 78%, 85%, 95% and 99% of isolates, respectively. In 298 contrast, similar frequencies of determinants coding for resistance to macrolides 299 (>98%), tetracyclines (between 50-63%) and oxazolidinones (between 2-12%) 300 were found between animal and clinical clades (Supp. fluoroquinolone resistance were also much more highly prevalent in clinical clades 306 (>98% for CRSs) vs animal branches (2.7%; p<0.001).
307
Genes encoding putative surface adhesin proteins (e.g., acm, scm, esp, sgrA, 308 fms6 and fms22) and two of the pilus-forming clusters were significantly more 309 common in the CRSs, (p-values below 0.001 in all cases) compared to animal 310 isolates (Supp. Table 3 ). We next compared the presence/absence of putative 311 mobile elements between animal branches vs. CRSs. On average, the number of 312 insertion sequences in the former were 5.7, whereas the clinical subclades had 6.9 313 (6.76 CRS-I and 7.06 for CRS-II). Of note, rep17 was notoriously overrepresented 314 in the CRSs (Supp. Rates of evolution across the whole population of E. faecium 319 Using the sampling date of isolates within clade A, we performed molecular clock 320 analyses on the entire clade A and its subgroups (animal branches, CRS-I and 321 CRS-II). We found that the oldest split within clade A likely occurred ~3,585 years Our results indicate that VREfm is widely present in Latin America but that their 338 frequency and population structure seem to vary from country to country. As Figure 2) . Additionally, we found a lack of concordance 379 18 between MLST classification and the clades. The discrepancy is likely explained by 380 the presence of recombinant regions in the MLST genes, low variation in some of 381 the loci, and the absence of pst in many isolates 19, 20, 43 382 Previous studies estimated that the separation between clades A and B occurred 383 2776 ± 818 y.a. 3 , a time frame that is similar to our results. However, the previously 384 reported split between animal branches and the clinically-related subclades was 385 reported to occur 74 ± 30 y. a., which is much more recent than what we found.
386
Our findings showed at least a tenfold lower mutation rate from what has been 387 previously reported 3,18 . This finding could be associated with the larger genomic 
396
Our study could be subject to sampling bias due to small sample size of genomes 397 from Latin America, but we attempted to include as many and as diverse genomes Europe, North America, Asia, Africa, and Australia ( Supplementary Table 1 ).
469
Accordingly to the source, the E. faecium genomes were grouped into different CRISPRfinder 56 and BLASTX searches using Cas system proteins 57 as templates.
491
All BLASTX hits were selected if they had an identity percentage higher or equal to 492 95% and a coverage of at least 80% of the target sequence. For BLASTN 493 searches, hits were selected if they had an identity percentage higher than 90% 494 and a coverage of at least 80% of the target sequence. To identify statistically 495 significant differences across proportions of the evaluated characteristics among 496 pairs of clades found, a Z-test was performed (α=0.01). Table 4 ). These positions were used to create a random forest amino acid changes were selected for the classification based on their 511 discrimination power using recursive elimination process of those with lower score.
512
Next, the model was tested on the whole dataset of PBP5 sequences and had a 513 100% specificity with 96% sensitivity, which resulted in 6 cases of major errors 514 were the isolate was resistant but predicted to be susceptible. 515 516 Phylogenetic analysis 517 We built a phylogenetic tree based on the core genome of 55 representative 518 genomes from our collection, including the genome Com15 as outgroup. The core 519 genome was obtained with Roary 58 and each of the orthogroups was aligned with 520 MUSCLE v3.8 59 . A Maximum Likelihood (ML) guide tree was built with RAxML 521 8.2.11 60 using a GTR+Γ model. Using Bayesian approach, we estimated a 522 Maximum Clade Credibility (MCC) tree based on 20 million trees in BEASTv1.8 61 . 523 We employed a constant population size, a GTR+Γ+I substitution model, default 524 prior probability distributions, and a chain length of 100 million steps with a burn-in 525 of 10 million and a 5000-step thinning and the ML as starting tree.
526
The phylogenetic tree for the whole population of E. faecium included all the 527 genomes (n=340) and two outgroups ( were the same as above with a chain length of 300 million steps, a burn-in of 80 534 million steps, and a random starting tree.
535
The second phylogenetic reconstruction included the genomes grouped into the 536 clade corresponding to the previously designed Clade A 3 . We realized pairwise 537 comparisons of the assemblies with Mummer 3.23 62 against the reference genome 538 Aus0085 (CP006620.1). The identified variants and the reference sequence were 539 used to create a multiple whole genome alignment and, with it, we built a guide 540 tree with RAxML 60 using the abovementioned parameters. This guide tree was 541 used later to obtain the recombinant regions in the alignment with 542 ClonalFrameML 33 for each isolate. Those regions were further removed from the 543 alignment and then used to produce a MCC tree with BEAST. The same run 544 parameters as above were used with a 50-million step burn-in.
545
Finally, a strict molecular clock analysis was performed on clade A strains. We All genomic data is available at GenBank database, accession numbers for the 559 sequenced genomes are listed in Supplementary Table 3 . The datasets generated 560 during and/or analysed during the current study are available from the 561 corresponding author on reasonable request. 562 563 Ethics declarations 564 We declare no ethical competing interest. In our study, we did not perform any 565 experiments with animals or higher invertebrates, neither performed experiments 566 on humans and/or the use of human tissue samples. Our data have been 567 originated from bacteria, not linked to clinical information, collected in previous 568 studies and following full ethical approvals. Also, additional genomic data that we 569 included for the analysis are available on public repositories (NCBI and published 570 articles). 
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